Osaic Holdings
INO icon

Osaic Holdings’s Inovio Pharmaceuticals INO Stock Holding History

Osaic Holdings’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02K Sell
933
-105
-10% -$125 ﹤0.01% 7478
2026
Q1 		$1.8K Buy
1,038
+72
+7% +$119 ﹤0.01% 7079
2025
Q4 		$1.68K Sell
966
-941
-49% -$2.07K ﹤0.01% 7142
2025
Q3 		$4.51K Buy
1,907
+258
+16% +$494 ﹤0.01% 6811
2025
Q2 		$3.34K Buy
1,649
+735
+80% +$1.41K ﹤0.01% 6753
2025
Q1 		$1.48K Sell
914
-2,609
-74% -$5.24K ﹤0.01% 6699
2024
Q4 		$6.44K Buy
3,523
+600
+21% +$2.66K ﹤0.01% 6051
2024
Q3 		$16.9K Buy
2,923
+157
+6% +$1.29K ﹤0.01% 5479
2024
Q2 		$22.3K Sell
2,766
-2,716
-50% -$28.6K ﹤0.01% 5269
2024
Q1 		$76.1K Buy
5,482
+1,093
+25% +$9.44K ﹤0.01% 4438
2023
Q4 		$26.9K Sell
4,389
-3,461
-44% -$17.1K ﹤0.01% 5325
2023
Q3 		$36.6K Sell
7,850
-21,498
-73% -$119K ﹤0.01% 5198
2023
Q2 		$158K Buy
29,348
+12,306
+72% +$99.2K ﹤0.01% 4085
2023
Q1 		$167K Buy
17,042
+3,636
+27% +$62K ﹤0.01% 4011
2022
Q4 		$251K Sell
13,406
-834
-6% -$18.9K ﹤0.01% 3658
2022
Q3 		$294K Sell
14,240
-717
-5% -$18.4K ﹤0.01% 3399
2022
Q2 		$311K Buy
14,957
+1,854
+14% +$52.3K ﹤0.01% 3393
2022
Q1 		$627K Buy
13,103
+1,988
+18% +$89.6K ﹤0.01% 3006
2021
Q4 		$668K Sell
11,115
-5,220
-32% -$418K ﹤0.01% 2780
2021
Q3 		$1.4M Buy
16,335
+3,412
+26% +$342K ﹤0.01% 2040
2021
Q2 		$1.44M Buy
12,923
+1,014
+9% +$97.4K ﹤0.01% 2012
2021
Q1 		$1.33M Sell
11,909
-296
-2% -$38.9K ﹤0.01% 1976
2020
Q4 		$1.3M Sell
12,205
-5,879
-33% -$783K ﹤0.01% 1805
2020
Q3 		$2.59M Buy
18,084
+6,844
+61% +$1.43M 0.01% 1160
2020
Q2 		$3.64M Buy
11,240
+6,606
+143% +$1.06M 0.01% 866
2020
Q1 		$419K Buy
+4,634
New +$286K ﹤0.01% 2246

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's INO Position: Q2 2026 in Review

Osaic Holdings reduced its Inovio Pharmaceuticals (INO) stake by 10% in Q2 2026, selling an estimated $125 and leaving 933 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #7478.

Osaic Holdings first reported a position in INO in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.64M in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Osaic Holdings held 933 shares of Inovio Pharmaceuticals worth $1.02K as of Q2 2026.
  • Osaic Holdings sold 105 Inovio Pharmaceuticals shares in Q2 2026, an estimated $125.
  • Inovio Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7478 holding.
  • Osaic Holdings first reported a position in Inovio Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Inovio Pharmaceuticals position peaked at $3.64M in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.